Quantcast

Latest ACE inhibitors Stories

2015-02-24 23:13:30

Heart Healthy for a Lifetime: Medicationdiscountcard.com Focuses on Access to Coupons for Heart-Related Medications During American Heart Month Houston, TX (PRWEB)

2015-02-13 12:27:21

- Decision could speed access to LCZ696 for heart failure with reduced ejection fraction patients in the US, reducing total review time from 12 to 8 months(1) EAST HANOVER, N.J., Feb.

2014-11-17 16:26:50

- New data from PARADIGM-HF shows LCZ696 cut incidence of sudden deaths, emergency room visits, hospitalizations, worsening symptoms and need for more intense treatment in HFrEF patients versus enalapril(1,2) EAST

2014-09-25 23:05:01

A recent breakthrough in clinical results with an experimental drug to treat heart failure has shown very promising results.

2014-09-15 12:28:16

Dr. Milton Packer and Dr. McMurray will be presenting these results for the first time in the United States at the HFSA Annual Meeting LAS VEGAS, Sept.

2014-09-08 08:32:02

DENVER, Sept. 8, 2014 /PRNewswire/ -- Silvergate Pharmaceuticals, Inc.

2014-08-30 12:20:58

-- LCZ696 mortality benefit exceeded what was achieved with enalapril, an ACE-inhibitor, when replacing enalapril combined with current treatment

2014-08-30 08:20:58

- Study showed significantly more HF-REF patients on LCZ696 regimen were alive, had fewer hospitalizations than those given enalapril regimen(1) EAST HANOVER, N.J., Aug.

2014-08-11 00:20:49

-- LCZ696 significantly reduced cardiovascular deaths in head to head study against enalapril, in addition to current best treatment, in patients with HF-REF EAST HANOVER, N.J., Aug.